On Tuesday, Shares of Facebook, Inc. (NASDAQ:FB), dropped -1.50% to $80.68.
Facebook app developers have until April 30 to switch their apps to the social network’s second version of its Graph API before being automatically switched.
Facebook product manager Simon Cross said in a blog post on Tuesday that the company would start upgrading all apps to Graph API version 2.0 on April 30.
The company first declared the new version of the Graph API, together with its new login with lightweight review process, at its F8 summit in April 2014.
Facebook claimed that the new version of the Graph API would assist developers build, grow, and monetise their apps, while the new Facebook login would give people more control over the information they share with apps.
While the new API and Facebook login were accessible to developers from that date, the company said at the time that it would migrate all apps to version 2.0 of its Graph API automatically by April this year. Already, many developers are migrating their apps, according to Facebook.
Starting April 30, Facebook will start upgrading all apps to the new login and second version of Graph API, and remove any permissions that, by that date, have not been approved via its login review. The migration will roll out to all apps over the course of a few weeks.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
Shares of salesforce.com, inc. (NYSE:CRM), declined -1.40% to $66.89, during its last trading session.
salesforce.com, stated that it granted equity awards under its 2014 Inducement Equity Incentive Plan to new employees who joined Salesforce in connection with its acquisition of Toopher Inc. The Plan was adopted by the Board of Directors in July 2014, in accordance with New York Stock Exchange Rule 303A.08.
Toopher is the leader in contextual multifactor authentication. Toopher’s strong, fast, invisible two-factor authentication delivers an entirely new level of protection with a world-class user experience. Salesforce accomplished its acquisition of Toopher in April 2015.
Under the Plan, Salesforce granted a total of 37,408 restricted stock units (“RSUs”) to 7 employees. These RSUs vest over 4 years with 25 percent of the RSUs vesting on the first anniversary of the grant date and the balance vesting quarterly thereafter in 12 equal installments, subject to continued service through each applicable vesting date. Each of the employees who received an equity award is a non-executive employee and joined as a result of the acquisition.
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship administration to various businesses and industries worldwide.
At the end of Tuesday’s trade, Shares of Sanofi (NYSE:SNY), dwindled -1.38% to $51.56.
Genzyme, a Sanofi company, declared recently that the Food and Drug Administration (FDA) has granted Fast Track designation for the development of GZ/SAR402671, a new investigational oral substrate reduction therapy for the treatment of Fabry disease.
FDA’s Fast Track Drug Development Program is designed to facilitate frequent interactions with the FDA review team to expedite the clinical development and review of a New Drug Application (NDA) for medicines with the potential to treat serious or life-threatening conditions and address unmet medical needs for such disease or conditions. It also provides the opportunity to submit sections of an NDA on a rolling basis before a sponsor submits the complete application. Genzyme is presently enrolling patients in its Phase 2a trial of GZ/SAR402671, and plans to enroll nine treatment-naïve male adult patients with Fabry disease in this international, multicenter study.
Fabry disease is a rare lysosomal storage disorder that results in abnormal tissue deposits of a particular fatty substance (called globotriaosylceramide, also referred to as GL-3 or Gb3) throughout the body. GZ/SAR402671 is a glucosylceramide synthase inhibitor that blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3.
Fabry disease is an inherited and progressive condition that is characterized by excessive accumulation of the lipid GL-3 in various organs and tissues.
Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, counting Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; and Afrezza, an inhaled insulin to improve glycemic control, in addition to Toujeo, an insulin glargine.
Finally, Jabil Circuit Inc. (NYSE:JBL), ended its last trade with -1.35% loss, and closed at $23.33.
Jabil Circuit, has been awarded a 2015 Gold Quill Merit Award from the International Association of Business Communicators (IABC) for their internal communications and employee engagement program, the Deliver Best Practices competition. The Gold Quill Awards recognize business communication excellence and are acknowledged as the most prestigious awards in the industry.
Since the inception of the program in 2009, more than 4000 teams have competed in four competition categories: Customer Satisfaction, Human Development, Operational Excellence and Social & Environmental Responsibility. The teams compete at three rounds (Plant, Sub-Regional and Regional) before advancing to the Preliminary and Final round of the Global Competition. During the last two rounds, the top 32 finalist teams send representatives to Jabil’s headquarters in St. Petersburg, Florida to present their projects to Jabil’s executives and to spend a week getting to know colleagues from other Jabil teams and sites.
By leading or participating in projects, employees directly impact Jabil’s operations through improved customer satisfaction, improved quality and efficiency, employee engagement and satisfaction. Employees report professional and personal growth counting acquiring new skills and knowledge, improving their teamwork talents and generating greater visibility for their projects among peers and executive administration. “I think Deliver Best Practices is more than just a competition. It is a platform to share Jabil’s culture. It really provides a chance for us to be proud of working for such a great company,” said Amy Shen a Jabil employee from Taichung’s Design operation and Human Development category winner of the 2014 Deliver Best Practices.
Jabil Circuit, Inc., together with its auxiliaries, provides electronic manufacturing services and solutions worldwide. It offers electronics design, production, and product administration services to companies in the aerospace, automotive, computing, defense, digital home, energy, healthcare, industrial, instrumentation, lifestyles, mobility, mold, networking, packaging, peripherals, storage, telecommunications, and wearable technology industries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
